Ardent Health, Inc.

Forward-Looking Statements

This press release may contain "forward-looking statements," as that term is defined in the U.S. federal securities laws.

These forward-looking statements include, but are not limited to, statements other than statements of historical facts,

including, among others, statements relating to our future financial performance, our business prospects and strategy,

anticipated financial position, liquidity and capital needs, the industry in which we operate and other similar matters.

Words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "could," "would,"

"will," "may," "can," "continue," "potential," "should" and the negative of these terms or other comparable terminology

often identify forward-looking statements. When reviewing this press release, you should keep in mind the substantive risk

and uncertainties that could impact our business. These forward-looking statements are not guarantees of future

performance and are subject to risks and uncertainties that could cause actual results to differ materially from the results

contemplated by the forward-looking statements. These risks and uncertainties could cause actual results to differ

materially from those projected in forward-looking statements contained in this press release or implied by past results and

trends. Our historical results are not necessarily indicative of the results that may be expected for any period in the future.

Factors, risks, and uncertainties that could cause actual outcomes and results to be materially different from those

contemplated include, among others: (1) general economic and business conditions, both nationally and in the regions in

which we operate, including the impact of challenging macroeconomic conditions and inflationary pressures, current

geopolitical instability, and impacts from the imposition of, or changes in, tariffs, as well as the potential impact on us of

uncertain political, financial, credit and capital conditions; (2) possible reductions or other changes in Medicare, Medicaid

and other state programs, including Medicaid supplemental payment programs, Medicaid waiver programs or state

directed payments, that could have an adverse effect on our revenues and business; (3) reduction in the reimbursement

rates paid by commercial payors, increased reimbursement denials or payment delays by commercial payors, our inability

to retain and negotiate favorable contracts with private third party payors, or an increasing volume of uninsured or

underinsured patients; (4) effects of changes in healthcare policy or legislation, including the One Big Beautiful Bill Act (the

"OBBBA") and any other reforms that have or may be undertaken by the current presidential administration, and legal and

regulatory restrictions on our hospitals that have physician owners; (5) the ability to achieve operating and financial targets,

develop and execute mitigation plans to offset to the extent possible impacts from the OBBBA, the expiration of temporary

enhanced subsidies for individuals eligible to purchase insurance coverage through health insurance marketplaces and

imposition of tariffs, attain expected levels of patient volumes and revenues, and control the costs of providing services; (6)

security threats, catastrophic events and other disruptions affecting our, our service providers’ or our joint venture ("JV")

partners’ information technology and related systems, which have adversely affected, and could in the future adversely

affect, our relationships with patients and business partners and subject us to legal claims and liabilities, reputational harm

and business disruption and adversely affect our financial condition; (7) the highly competitive nature of the healthcare

industry and continued industry trends towards clinical transparency and value-based purchasing may impact our

competitive position; (8) inability to recruit and retain quality physicians and increased labor costs resulting from increased

competition for staffing or a continued or increased shortage of experienced nurses, as well as the loss of key personnel,

including key members of our management team; (9) changes to physician utilization practices and treatment

methodologies and other factors outside our control that impact demand for medical services and may reduce our

revenues and ability to grow profitability; (10) continued industry trends toward value-based purchasing, third party payor

consolidation and care coordination among healthcare providers; (11) inability to successfully complete acquisitions,

divestitures or strategic JVs or inability to realize all of the anticipated benefits; (12) liabilities because of professional

liability and other claims brought against our hospitals, physician practices, outpatient facilities or other business

operations; (13) exposure to certain risks and uncertainties by the JVs through which we conduct a significant portion of our

operations, including anticipated synergies of past acquisitions and the risk that transactions may not receive necessary

government clearances; (14) failure to obtain drugs and medical supplies at favorable prices or sufficient volumes; (15)

operational, legal and financial risks associated with outsourcing functions to third parties; (16) our facilities are heavily

concentrated in Texas and Oklahoma, which makes us sensitive to regulatory, economic and competitive conditions and

changes in those states; (17) negative impact of severe weather, climate change, and other factors beyond our control,

which could restrict patient access to care or cause one or more facilities to close temporarily or permanently; (18) risks

related to the Master Lease with Ventas ("Ventas Master Lease") and its restrictions and limitations on our business; (19)

the impact of our significant indebtedness and the ability to refinance such indebtedness on acceptable terms; (20) our

failure to comply with complex laws and regulations applicable to the healthcare industry or to adjust our operations in

response to changing laws and regulations; (21) the impact of governmental claims or governmental investigations, payor

audits and litigation brought against our hospitals, physician practices, outpatient facilities or other business operations;

(22) actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards

and other requirements; (23) the impact of a deterioration of public health conditions associated with a future pandemic,

epidemic or outbreak of infectious disease; (24) inability to or delay in building, acquiring, selling, renovating or expanding

our healthcare facilities; (25) failure to comply with federal and state laws relating to Medicare and Medicaid enrollment,

permit, licensing and accreditation requirements; (26) the results of our efforts to use technology, including artificial

intelligence ("AI") and machine learning, to drive efficiencies, better outcomes and an enhanced patient experience; (27)

our status as a controlled company; (28) conflicts of interest between our controlling stockholder and other holders of our

common stock; and (29) other risk factors described in our filings with the Securities and Exchange Commission.

Many of the important factors that will determine these results are beyond our ability to control or predict. You are

cautioned not to put undue reliance on any forward-looking statements, which speak only as of the date of this press

release. Except as otherwise required by law, we do not assume any obligation to publicly update or release any revisions to

these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect the

occurrence of unanticipated events. All references to "Company," "Ardent Health," "Ardent," "we," "our" and "us" as used

throughout this release refer to Ardent Health, Inc. and its affiliates, unless stated otherwise or indicated by context.